Heron Therapeutics (HRTX) Q4 2022 Earnings

23MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.63
-0.48
-0.32
-0.17

Details

Expected EPS
-0.28
Actual EPS
-0.17
Surprise EPS
0.11
Surprise Percent
+39.29%

Description

Heron Therapeutics (HRTX) has reported earnings of -0.17 per share for Q4 2022.

0 Comments

Share your thoughts